HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[An intranasal method of revaccination against mumps].

Abstract
The effectiveness of revaccination against mumps was studied using different routes for administration of a live mumps vaccine from L-3 strain. Poor reactogenicity of the vaccine was observed after intranasal administration. The highest rise in titres of virus-neutralizing antibody was demonstrated in volunteers given the vaccine by the intranasal route. Revaccination of adults by both intranasal and subcutaneous routes induced production of antigen-specific memory cells. The results of the study attest to the usefulness of the intranasal route of vaccine administration in revaccinations against epidemic parotitis.
AuthorsV P Krasnova, N V Iuminova, V A Liashenko
JournalVoprosy virusologii (Vopr Virusol) 1994 Jan-Feb Vol. 39 Issue 1 Pg. 24-6 ISSN: 0507-4088 [Print] Russia (Federation)
Vernacular TitleIntranazal'nyĭ sposob revaktsinatsii protiv épidemicheskogo parotita.
PMID8160444 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antibodies, Viral
  • Mumps Vaccine
Topics
  • Administration, Intranasal
  • Adolescent
  • Adult
  • Antibodies, Viral (blood)
  • Humans
  • Immunization, Secondary (methods)
  • Injections, Subcutaneous
  • Lymphocyte Activation
  • Mumps (immunology, prevention & control)
  • Mumps Vaccine (administration & dosage, adverse effects)
  • Mumps virus (immunology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: